Denmark permanently suspends use of AstraZeneca vaccine. Health authorities see a relationship with thrombi and prefer other injectables. Here you can consult all about AstraZeneca vaccine: necessary dose, side effects, etc .
The Danish health authorities will permanently suspend the AstraZeneca vaccine against covid-19 after having interrupted its use for five weeks following the rare cases of thrombosis in several European countries.
The country’s General Directorate of Health has considered that there is a probable connection between this injectable and abnormal cases of thrombosis. And he has taken into account that there are enough vaccines on the market and that the epidemic situation in the country is under control.
Despite this, the Danish health authorities have said they are “in complete agreement” with the European Medicines Agency (EMA) that AstraZeneca’s vaccine is “safe and effective” against COVID-19, although they have emphasized that the decision end is from each country.
There is a greater risk of suffering thrombi caused by covid than by vaccination
The suspension of AstraZeneca, of which Denmark has bought 2.4 million doses, will cause a delay of several weeks in the vaccination schedule of this Nordic country, which intended to have its entire population immunized by the end of July.
The EU will not renew contracts with Astrazeneca and Johnson & Johnson, according to ‘La Stampa’
Denmark had been the first to suspend vaccination with AstraZeneca on March 11, a decision that was later followed by most European countries, although they resumed the process when the European Medicines Agency (EMA) assured that there was no evidence of a direct relationship with the detected cases of thrombosis .
However, some countries have reserved its use for people over 60 years of age, such as Germany and Sweden, while Norway will announce in a few days what decision it will make on the vaccine, also suspended for a month.
In its previous appearance, on March 25, the Danish Medicines Agency argued the extension of the suspension due to the need to finish studying several unusual cases, although it defended the efficacy and safety of the vaccine.
Denmark has registered a death with this clinical picture, which includes a low number of platelets, clots in blood vessels and hemorrhages; and a couple of cases of deceased with similar symptoms that had not yet been analyzed at the end of March.